saliva concentration
Recently Published Documents


TOTAL DOCUMENTS

17
(FIVE YEARS 2)

H-INDEX

4
(FIVE YEARS 0)

2021 ◽  
pp. 000348942098634
Author(s):  
Jerome R. Lechien ◽  
Francois Bobin ◽  
Didier Dequanter ◽  
Alexandra Rodriguez ◽  
Serge Le Bon ◽  
...  

Objective: To study the profile and the therapeutic response of patients with laryngopharyngeal reflux (LPR) at the hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring (HEMII-pH) according to the initial pepsin saliva concentration. Methods: From January 2018 to January 2020, patients with positive LPR diagnosis at the HEMII-pH were consecutively recruited from 3 European Hospitals. Saliva pepsin concentration (Peptest™) was measured during the HEMII-pH testing period and patients were classified into 2 groups: negative versus positive Peptest. The clinical outcomes, that is, gastrointestinal and HEMII-pH findings, reflux symptom score-12 (RSS-12), and 3-month therapeutic response, were compared between groups. Results: A total of 124 patients completed the study. Among them, 30 patients had negative Peptest. Pharyngeal reflux events occurred outside 1-hour post-meal time in 74.0%, after the meals in 20.5% and nighttime in 5.5%. The pepsin saliva level was not significantly associated with the reflux events preceding the sample collection. Patients with positive Peptest had better improvement of RSS-12 digestive and respiratory subscores and oral, pharyngeal, and laryngeal findings compared with patients with negative Peptest. Conclusion: Patients with high saliva pepsin concentration had no stronger gastrointestinal, HEMII-pH, or clinical outcomes compared with those with low or undetectable saliva pepsin concentration.


2021 ◽  
Vol 19 (6) ◽  
pp. 37-42
Author(s):  
Natalia Sergeevna Linkova ◽  
Anastasiia Eduardovna Pychalskaya ◽  
Andrey Nikolaevich Il’nitskii ◽  
Uliana Alexandrovna Novak-Bobarikina ◽  
Ol’ga Alexandrovna Osipova ◽  
...  

Drug Research ◽  
2018 ◽  
Vol 69 (06) ◽  
pp. 348-351
Author(s):  
Nasir Idkaidek ◽  
Ahmad Al-Ghazawi

AbstractPharmacokinetics of paracetamol (APAP) was studied on-board during an air flight and compared to those on ground after 500 mg oral dose in 20 healthy human volunteer in parallel design study. Saliva samples were obtained every 15 min up to 2 h after dosing. Pharmacokinetic parameters were calculated by non compartmental analysis and one compartment models using Winnonlin program V5.2. Results have showed that on-board to ground ratios for area under curves AUC0→1, AUC0→2, time to reach maximum saliva concentration Tmax, absorption rate constant Ka and maximum saliva concentration Cmax were 0.62, 0.38, 1.01, 0.81 and 0.79 respectively. Effective membrane permeability coefficients were optimized by Nelder-Mead algorithm using Simcyp program V13. This showed similar rate of absorption and early exposure up to one hour, and lower bioavailability after 1 h on-board. This can be explained by the increased liver blood flow at high altitude that led to increased liver metabolism on-board. However, APAP elimination parameters were not calculated due to short sampling time. This suggests a need for dose adjustment on-board during long air flights, especially for narrow therapeutic index drugs with flow limited metabolism.


2018 ◽  
Vol 30 (4) ◽  
pp. 246 ◽  
Author(s):  
Marina Grgurevic ◽  
Faris Zvizdic ◽  
Azra Nalbantic ◽  
Elmedina Jahic ◽  
Nerma Resic ◽  
...  

2014 ◽  
Vol 7 (2) ◽  
pp. 110-114 ◽  
Author(s):  
Rui Oliveira ◽  
Eunice Navas ◽  
Carolina Duran ◽  
Maria Pinto ◽  
Jose Gutierrez ◽  
...  

2011 ◽  
Vol 12 (4) ◽  
Author(s):  
Abdualrahman M. Abdualkader ◽  
Ahmed Merzouk ◽  
Abbas Mohammed Ghawi ◽  
And Mohammed Alaama

Leeches were fed on the phagostimulatory solution through parafilm membrane. The satiated leeches were forced to regurgitate the solution by soaking them in an ice-container. The anticoagulant activity was ascertained using thrombin time assay (TT). The result revealed that the saliva concentration which increases TT by 100% (IC100) is 43.205µg/ml plasma. The antimicrobial activity of the saliva was tested against several bacterial spp. (E.coli, P.aeruginosa, B.cereus, Sal.typhi and S.aureus)  and fungi spp. (C.albicans and C.neoformans). It was found that saliva has an inhibition activity against Sal.typhi (minimal inhibitory concentration MIC 78.253µg/ml), S.aureus (MIC 78.253µg/ml) and E.coli (MIC 121.256µg/ml).ABSTRAK: Pacat-pacat diberi makan larutan phagostimulatory menerusi membran parafilem. Pacat-pacat yang kekenyangan itu dipaksa memuntahkan larutan tersebut dengan direndam di dalam bekas berisi ais. Aktiviti antigumpal ditentukan menggunakan cerakin masa trombin (TT). Keputusan menunjukkan kepekatan air liur pacat menyebabkan pertambahan TT sebanyak 100% (IC100) iaitu 43.205µg/ml plasma. Aktiviti antimikrob air liur telah diuji dengan pelbagai jenis bakteria (E.coli, P.aeruginosa, B.cereus, Sal.typhi dan S.aureus) dan pelbagai jenis kulat (C.albicans and C.neoformans). Didapati air liur menghasilkan aktiviti perencatan terhadap Sal.typhi (kepekatan perencat minima (Minimal inhibitory concentration - MIC) 78.253µg/ml), S.aureus (MIC 78.253µg/ml) dan E.coli (MIC 121.256µg/ml).


2002 ◽  
Vol 9 (1) ◽  
pp. 15-18 ◽  
Author(s):  
Sabinus I. Ofoefule ◽  
Chioma E. Obodo ◽  
Orish E. Orisakwe ◽  
Johnson O. Afonne ◽  
Ndidiamaka A. Ilondu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document